A third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients

BACKGROUND & AIMS: Immune responses of solid organ transplant recipients to 2 doses of the BNT162b2 mRNA anti-SARS-CoV-2 vaccine are impaired. The immunogenicity and safety of a third dose among liver transplant (LT) recipients are unknown. This work aimed to evaluate the immune response of LT r...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidov, Yana, Indenbaum, Victoria, Tsaraf, Keren, Cohen-Ezra, Oranit, Likhter, Mariya, Ben Yakov, Gil, Halperin, Rebecca, Levy, Itzchak, Mor, Orna, Agmon-Levin, Nancy, Afek, Arnon, Rahav, Galia, Lustig, Yaniv, Ben Ari, Ziv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015954/
https://www.ncbi.nlm.nih.gov/pubmed/35452692
http://dx.doi.org/10.1016/j.jhep.2022.03.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015954/
https://www.ncbi.nlm.nih.gov/pubmed/35452692
http://dx.doi.org/10.1016/j.jhep.2022.03.042

Ejemplares similares